Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment.

MLA

Epitropoulos, Alice T., and Jamie L. Weiss. “Topical Human Recombinant Nerve Growth Factor for Stage 1 Neurotrophic Keratitis: Retrospective Case Series of Cenegermin Treatment.” American Journal of Ophthalmology Case Reports, vol. 27, July 2022, p. 101649. EBSCOhost, https://doi.org/10.1016/j.ajoc.2022.101649.

APA

Epitropoulos, A. T., & Weiss, J. L. (2022). Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment. American Journal of Ophthalmology Case Reports, 27, 101649. https://doi.org/10.1016/j.ajoc.2022.101649

Chicago

Epitropoulos, Alice T, and Jamie L Weiss. 2022. “Topical Human Recombinant Nerve Growth Factor for Stage 1 Neurotrophic Keratitis: Retrospective Case Series of Cenegermin Treatment.” American Journal of Ophthalmology Case Reports 27 (July): 101649. doi:10.1016/j.ajoc.2022.101649.